BCM
AGN

Bayesian Capital Management’s Allergan plc AGN Stock Holding History

Bayesian Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,208
Closed -$230K – 861
2018
Q3 		$230K Sell
1,208
-3,264
-73% -$600K 0.04% 528
2018
Q2 		$746K Buy
+4,472
New +$718K 0.17% 167
2017
Q4 		– Sell
-3,200
Closed -$656K – 792
2017
Q3 		$656K Buy
+3,200
New +$744K 0.16% 210
2016
Q3 		– Sell
-1,035
Closed -$239K – 569
2016
Q2 		$239K Buy
+1,035
New +$239K 0.14% 278

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

Bayesian Capital Management's AGN Position: Q4 2018 in Review

Bayesian Capital Management sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 1,208 shares — an estimated $230K sold.

Bayesian Capital Management first reported a position in AGN in Q2 2016 and held it in 4 quarters. The position peaked at $746K in Q2 2018. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Bayesian Capital Management reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Bayesian Capital Management sold 1,208 Allergan plc shares in Q4 2018, an estimated $230K.
  • Bayesian Capital Management first reported a position in Allergan plc in Q2 2016 and held it in 4 quarters.
  • Bayesian Capital Management's Allergan plc position peaked at $746K in Q2 2018.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Bayesian Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.